{"id":"mc2-01-cream","safety":{"commonSideEffects":[{"rate":null,"effect":"Local skin irritation"},{"rate":null,"effect":"Skin atrophy"},{"rate":null,"effect":"Contact dermatitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a topical corticosteroid cream, MC2-01 works by binding to glucocorticoid receptors in skin cells, suppressing inflammatory cytokine production and immune cell infiltration. This reduces erythema, pruritus, and other inflammatory manifestations of dermatological conditions. The cream formulation allows for localized delivery to affected areas while minimizing systemic absorption.","oneSentence":"MC2-01 cream is a topical corticosteroid formulation designed to reduce inflammation and provide therapeutic benefit when applied to affected skin areas.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:20:23.168Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory skin conditions (specific indication not publicly detailed)"}]},"trialDetails":[{"nctId":"NCT07357831","phase":"PHASE3","title":"A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects","status":"RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2025-12-26","conditions":"Plaque Psoriasis","enrollment":537},{"nctId":"NCT03308799","phase":"PHASE3","title":"A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2017-10-03","conditions":"Psoriasis Vulgaris","enrollment":794},{"nctId":"NCT03819218","phase":"PHASE2","title":"A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects","status":"TERMINATED","sponsor":"MC2 Therapeutics","startDate":"2018-12-27","conditions":"Psoriasis Vulgaris","enrollment":7},{"nctId":"NCT03802344","phase":"PHASE3","title":"This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2018-12-12","conditions":"Psoriasis Vulgaris","enrollment":498},{"nctId":"NCT03899064","phase":"PHASE1","title":"Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2019-02-13","conditions":"Photoallergy","enrollment":58},{"nctId":"NCT03892564","phase":"PHASE1","title":"Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2019-02-27","conditions":"Phototoxicity","enrollment":35},{"nctId":"NCT03758365","phase":"PHASE1","title":"Evaluation of the Vasoconstriction Properties of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2018-11-05","conditions":"Vasoconstriction","enrollment":36},{"nctId":"NCT03462927","phase":"PHASE2","title":"A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2018-02-08","conditions":"Psoriasis Vulgaris","enrollment":63}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":21642,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Calcipotriol + Betamethasone dipropionate cream"],"phase":"phase_3","status":"active","brandName":"MC2-01 cream","genericName":"MC2-01 cream","companyName":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","companyId":"hangzhou-zhongmei-huadong-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MC2-01 cream is a topical corticosteroid formulation designed to reduce inflammation and provide therapeutic benefit when applied to affected skin areas. Used for Inflammatory skin conditions (specific indication not publicly detailed).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":3},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}